| Report ID | Date of report | Patient age | Patient gender |
| 21024 | Dec, 24, 2005 | 46 | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Zyprexa | olanzapine |
| Name |
Blood Cholesterol Increased |
Blood Triglycerides Increased |
Cholelithiasis |
Diabetes Mellitus |
Glycosylated Haemoglobin Increased |
High Density Lipoprotein Decreased |
Low Density Lipoprotein Increased |
Pancreatitis |
Skin Disorder |
Staphylococcal Infection |
Results from eHealthMe : 36981 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Blood Cholesterol Increased | 795 (2.15%) |
Blood Triglycerides Increased | 909 (2.46%) |
Cholelithiasis | 245 (0.66%) |
Diabetes Mellitus | 3855 (10.42%) |
Glycosylated Haemoglobin Increased | 180 (0.49%) |
High Density Lipoprotein Decreased | 71 (0.19%) |
Low Density Lipoprotein Increased | 95 (0.26%) |
Pancreatitis | 1610 (4.35%) |
Skin Disorder | 29 (0.08%) |
Staphylococcal Infection | 81 (0.22%) |
Top 3 (total: 4151. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Seroquel | 4610 (2.83%) |
Risperdal | 3423 (2.10%) |
Depakote | 2997 (1.84%) |
Death reported: 1347 (3.64% of total reports)
| Name | Count (% of total reports) |
Diabetes Mellitus | 3855 (10.42%) |
Weight Increased | 3095 (8.37%) |
Pancreatitis | 1610 (4.35%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
